Respreeza - supply shortage
Resolved
alpha1-proteinase inhibitor (human)
Shortage
Human
Shortage information
The shortage affecting Respreeza has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- Respreeza
- Supply shortage status
- Resolved
- International non-proprietary name (INN) or common name
- alpha1-proteinase inhibitor (human)
- Therapeutic area (MESH)
- Genetic Diseases, Inborn
- Lung Diseases
- Pharmaceutical forms affected
- Powder and solvent for solution for infusion
- Strengths affected
- 1,000 mg
- 4,000 mg
- 5,000 mg
- Availability of alternatives
- Yes
Key dates
- First published
- Last updated